BNET Industries

Market Cap:$147.5B
Last Fiscal Year Sales:$48.4B
- Public
- US
Dow Jones Description
Taking care of you and your four-legged friends too! Pfizer Inc. (NYSE: PFE), based in New York, NY, discovers, develops, manufactures and sells prescription medications for humans and animals. Employing about 115,000 people, this $51.3 billion company operates in three segments: Human Health, Consumer Healthcare and Animal Health. Together, these segments cover treatments for diseases such as cardiovascular and metabolic diseases, medications for oral care, tobacco dependence, and products for prevention and treatment of diseases in livestock and pets.
Number of Employees 81,800
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
Susan Kim: Menopause: Marketing Fear
-
Takeda, Pfizer To Co-Promote Actos Type 2 Diabetes Drug In China - Update
-
Pfizer Raises Quarterly Dividend 13%, See More Annual Hikes
-
REG-Pfizer Inc Pfizer Declares an 18-Cent First-Quarter 2010 Dividend
-
BRIEF: SEC probing insider-trading allegations
-
Pfizer joins partnership with Calif. firm: Collaboration planned with Crown Bioscience for cancer research
-
Research and Markets: The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to...
-
Science and Technology: Pfizer to buy Croatian drug patent
-
Bristol-Myers Squibb Raises Exchange Offer Price For Mead Johnson Shares - Update
-
'IT boosts efficiency & innovation'
-
Inspector General Saved Billions in Healthcare This Year
-
Private security firms no longer able to provide police information checks
-
Reportlinker Adds Growth Factors Blood And Tissue - A World Report
-
Market Report -- In Play PFE
-
Protalix Completes NDA Submission for taliglucerase alfa for the Treatment of Gaucher's Disease
-
Pfizer Inc. PFE JOBS Acquires Rights to Protalix Biotherapeutics's Gaucher Drug in Deal Worth $115M
-
Conservationists salute two corporations
-
Pfizer PFE Will Not Renew Ethical Distribution Agreement Term with MWI Veterinary Supply MWIV
-
2009: The Year That Was For Pfizer
News & Analysis
Filter by
pfizer inc. and webcast - All News and Analysis
Pfizer Invites Public to View and Listen to Webcast of Pfizer Participation at Healthcare Conference
NEW YORK -- Pfizer Inc invites investors and the general public to view and listen to a webcast of a presentation by Martin Mackay, President, Pfizer Global Research & Development, at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference on Wednesday, June 11th at 10:40 a.m. Pacific Daylight Saving Time.
Pfizer Invites Public to View and Listen to Webcast of June 2 Pfizer Analyst and Investor Meeting at ASCO
NEW YORK -- Pfizer Inc invites investors and the general public to view and listen to a webcast of a meeting with investment analysts and institutional investors to be held on Monday, June 2, at 6:00 p.m. Central Daylight Saving Time, in connection with the annual meeting of the American...
Pfizer Invites Public to View and Listen to Webcast of Pfizer Participation at Healthcare Conference
NEW YORK -- Pfizer Inc invites investors and the general public to view and listen to a webcast of a presentation by Pfizer Inc Chief Financial Officer, Frank D'Amelio, at the Citigroup Healthcare Conference on Wednesday, May 21st, at 3:30pm Eastern Daylight Saving Time.
Pfizer Invites Public to View and Listen to Webcast of April 17 Conference Call with Analysts
NEW YORK -- Pfizer Inc invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10am EDT on Thursday, April 17. The purpose of the call is to provide an update on Pfizer's results, as reflected in the company's...
Pfizer Invites Public to View and Listen to Webcast of Pfizer Participation at Healthcare Conference
NEW YORK -- Pfizer Inc invites investors and the general public to view and listen to a webcast of a presentation by Martin Mackay, President, Pfizer Global Research & Development, at the Lehman Brothers Global Healthcare Conference on Wednesday, March 19th at 10:45 a.m. Eastern Daylight Savings Time.
Pfizer Invites Public to View and Listen to Webcast of Pfizer Participation at Healthcare Conference
NEW YORK -- Pfizer Inc invites investors and the general public to view and listen to a webcast of a presentation by Pfizer Inc. Chief Medical Officer, Joseph Feczko, at the Cowen and Company 28th Annual Healthcare Conference on Monday, March 17th at 11:30 a.m. Eastern Daylight Savings Time.
Pfizer Invites Public to View and Listen to Webcast of January 23 Conference Call with Analysts
NEW YORK -- Pfizer Inc invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 12 Noon EST on Wednesday, January 23. The purpose of the call is to provide an update on Pfizer's results, as reflected in the...
Pfizer Invites Public to View and Listen to Webcast of November 30 Analyst Meeting in Hong Kong
NEW YORK -- Pfizer Inc invites investors and the general public to view and listen to a webcast of a meeting with investment analysts to be held on Friday, November 30, at 12:00p.m. Hong Kong Time (Thursday, November 29, at 11:00p.m. Eastern Daylight Savings Time). The analyst meeting will include...
Pfizer Invites Public to View and Listen to Webcast of October 18 Conference Call with Analysts
NEW YORK -- Pfizer Inc invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 12 Noon EDST on Thursday, October 18. The purpose of the call is to provide an update on Pfizer's results, as reflected in the...
Pfizer Invites Public to View and Listen to Webcast of Pfizer Participation at Healthcare Conference
NEW YORK -- Pfizer Inc invites investors and the general public to view and listen to a webcast of a presentation by Martin Mackay, Vice President, Pfizer Global Research & Development, Senior Vice President Worldwide Development, at the UBS Life Sciences Conference on Wednesday, September 26 at 8:30am Eastern Daylight...
Industry Transcripts by Seeking Alpha
-
Peregrine Pharmaceuticals Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Dec 10, 2009about PPHM
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Why J&J's Stelara Launch Should Target Dermatologists First 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- More Tysabri Problems; Time for a Biogen-Idec Credibility Check 3 votes
